Obesity

Body Fat Distribution, Fasting Insulin Levels, and Insulin Secretion: A Bidirectional Mendelian Randomization Study

J Clin Endocrinol MetabPublished Two-sample bidirectional Mendelian randomization study

Authors' conclusion

Although these results will need to be supported by experimental investigations, results of this MR study suggest that abdominal adiposity may be a key determinant of circulating insulin levels. Alternatively, insulin secretion may promote peripheral adipose tissue accumulation.

Study context

Population
Summary statistics from large-scale GWAS: Body mass index (BMI), waist to hip ratio adjusted for BMI (WHRadjBMI), abdominal subcutaneous, visceral and gluteofemoral adipose tissue, fasting insulin (FI) levels, pancreatic islets gene expression, hypothalamus gene expressionGWAS summary statistics · BMI 806,834 · WHRadjBMI 694,649 · gluteofemoral adipose tissue 38,965 · FI levels 98,210 · pancreatic islets gene expression 420 · hypothalamus gene expression 155
Comparison
Body fat accumulation/distribution vs fasting insulin levels
Outcome
Direction of causal effects between fasting insulin levels and body fat accumulation/distribution
Methodological detailsinverse variance-weighted and robust Mendelian randomization (MR) methods, multivariable MR, statistically and biologically driven genetic instruments
  • Inverse variance-weighted and robust MR methods
  • Multivariable MR
  • Statistically and biologically driven genetic instruments

Main finding

As reported in the abstract

Multivariable MR (waist circumference and BMI mutually adjusted): direct effect of waist circumference on FI vs effect of BMI on FI

2.43 times larger

Original publication

Body Fat Distribution, Fasting Insulin Levels, and Insulin Secretion: A Bidirectional Mendelian Randomization Study. J Clin Endocrinol Metab. Published 31 December 2022. doi:10.1210/clinem/dgac758

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.